Literature DB >> 24786631

Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Nicole C Berchtold1, Marwan N Sabbagh2, Thomas G Beach2, Ronald C Kim3, David H Cribbs4, Carl W Cotman4.   

Abstract

Mild cognitive impairment (MCI) represents a cognitive state intermediate between normal aging and early Alzheimer's disease (AD). To investigate if the molecular signature of MCI parallels the clinical picture, we use microarrays to extensively profile gene expression in 4 cortical brain regions (entorhinal cortex, hippocampus, superior frontal gyrus, post-central gyrus) using the postmortem tissue from cognitively normal aged controls, MCI, and AD cases. Our data reveal that gene expression patterns in MCI are not an extension of aging, and for the most part, are not intermediate between aged controls and AD. Functional enrichment analysis of significant genes revealed prominent upregulation in MCI brains of genes associated with anabolic and biosynthetic pathways (notably transcription, protein biosynthesis, protein trafficking, and turnover) as well as mitochondrial energy generation. In addition, many synaptic genes showed altered expression in MCI, predominantly upregulation, including genes for central components of the vesicle fusion machinery at the synapse, synaptic vesicle trafficking, neurotransmitter receptors, and synaptic structure and stabilization. These data suggest that there is a rebalancing of synaptic transmission in the MCI brain. To investigate if synaptic gene expression levels in MCI were related to cognitive function, Pearson correlation coefficient between the Mini Mental State Examination (MMSE) and region-specific messenger RNA expression were computed for MCI cases. A number of synaptic genes showed strong significant correlations (r > 0.8, p < 0.01) most notably in the entorhinal cortex, with fewer in the hippocampus, and very few in neocortical regions. The synaptic genes with highly significant correlations were predominantly related to synaptic transmission and plasticity, and myelin composition. Unexpectedly, we found that gene expression changes that facilitate synaptic excitability and plasticity were overwhelmingly associated with poorer MMSE, and conversely that gene expression changes that inhibit plasticity were positively associated with MMSE. These data suggest that there are excessive excitability and apparent plasticity in limbic brain regions in MCI, that is associated with impaired synaptic and cognitive function. Such changes would be predicted to contribute to increased excitability, in turn leading to greater metabolic demand and ultimately progressive degeneration and AD, if not controlled. Published by Elsevier Inc.

Entities:  

Keywords:  Electron transport; Entorhinal cortex; Hippocampus; Microarray; Mitochondria; Neurotransmitter receptor; SNARE; Somatosensory cortex; Superior frontal gyrus; Synapse

Mesh:

Year:  2014        PMID: 24786631      PMCID: PMC4067010          DOI: 10.1016/j.neurobiolaging.2014.03.031

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  74 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

2.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

3.  Differential effects of the APOE genotype on brain function across the lifespan.

Authors:  N Filippini; K P Ebmeier; B J MacIntosh; A J Trachtenberg; G B Frisoni; G K Wilcock; C F Beckmann; S M Smith; P M Matthews; C E Mackay
Journal:  Neuroimage       Date:  2010-08-10       Impact factor: 6.556

4.  Increased basal forebrain metabolism in mild cognitive impairment: an evidence for brain reserve in incipient dementia.

Authors:  Min-Jeong Kim; Kyoung-Min Lee; Young-Don Son; Hyeon-Ae Jeon; Young-Bo Kim; Zang-Hee Cho
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.

Authors:  Hakjoo Lee; Stephen J Raiker; Karthik Venkatesh; Rebecca Geary; Laurie A Robak; Yu Zhang; Hermes H Yeh; Peter Shrager; Roman J Giger
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

6.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

7.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 8.  The entorhinal cortex and neurotrophin signaling in Alzheimer's disease and other disorders.

Authors:  Helen E Scharfman; Moses V Chao
Journal:  Cogn Neurosci       Date:  2013-08-25       Impact factor: 3.065

9.  The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.

Authors:  L Hu; T P Wong; S L Côté; K F S Bell; A C Cuello
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

View more
  46 in total

Review 1.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

Review 2.  Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes.

Authors:  Giuseppe Lupo; Silvana Gaetani; Emanuele Cacci; Stefano Biagioni; Rodolfo Negri
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

3.  Transcriptomic changes in the prefrontal cortex of rats as a function of age and cognitive engagement.

Authors:  Michael R Duggan; Surbhi Joshi; Yin-Fei Tan; Michael Slifker; Eric A Ross; Mathieu Wimmer; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2019-06-08       Impact factor: 2.877

Review 4.  Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.

Authors:  Ashley Swanson; Tovah Wolf; Alli Sitzmann; Auriel A Willette
Journal:  Behav Brain Res       Date:  2018-02-17       Impact factor: 3.332

5.  Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Diego Mastroeni; Omar M Khdour; Elaine Delvaux; Jennifer Nolz; Gary Olsen; Nicole Berchtold; Carl Cotman; Sidney M Hecht; Paul D Coleman
Journal:  Alzheimers Dement       Date:  2016-10-25       Impact factor: 21.566

6.  Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.

Authors:  Niels R Reinders; Yvonne Pao; Maria C Renner; Carla M da Silva-Matos; Tessa R Lodder; Roberto Malinow; Helmut W Kessels
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

7.  Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.

Authors:  Elizabeth M Ellison; Erin L Abner; Mark A Lovell
Journal:  J Neurochem       Date:  2017-02       Impact factor: 5.372

8.  Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice.

Authors:  Jie Yang; Yan Long; De-Mei Xu; Bing-Lin Zhu; Xiao-Juan Deng; Zhen Yan; Fei Sun; Guo-Jun Chen
Journal:  J Mol Neurosci       Date:  2019-08-10       Impact factor: 3.444

9.  GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.

Authors:  Allison E Cherry; Juan Jesus Vicente; Cong Xu; Richard S Morrison; Shao-En Ong; Linda Wordeman; Nephi Stella
Journal:  Glia       Date:  2019-05-06       Impact factor: 7.452

10.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.